Specialty drugs, often high-cost treatments for chronic, complex, or rare conditions, present challenges in health care administration. In this session, we will evaluate the impact of administering specialty drugs under the medical-versus-pharmacy benefit, and we will focus on key differences in drug distribution, cost and flow of funds, clinical outcomes, and overall efficiency.
During this session, participants will gain insights into the evolving landscape of specialty drug administration and a deeper understanding of how various administration structures impact the delivery and effectiveness of specialty medications and the associated financial implications for payers and healthcare systems.